The Business Development Basics and Advanced Business Development courses support the activity that takes place at our partnering, investor and venture capital conferences each year by training individuals who are making the deals that drive this industry. Each course is taught by experienced business development professionals from leading pharmaceutical and biotechnology firms, and experts from the fields of law and public relations. All instructors have deep hands-on experience with deals and licensing in the biotech industry.
What’s the difference between the Basics course and the Advanced course?
The Basics course is an introductory-level course designed for professionals new to the life sciences business development field, or for individuals with some experience and who are interested in updating their knowledge and professional skills. Many participants who may already have some experience in licensing or business development will take this course as a refresher.
The Advanced course is designed for business development professionals with approximately 3-5 years experience who have most likely served as part of a business development or licensing team, but are now preparing to move to a more senior-level role within their organization. The course does assume participants know some of the vocabulary and tools used in licensing discussions, with more in-depth discussion of issues using real-world case studies. Each participant is put on a team to perform a mock negotiation over a clinical stage compound using valuation methodologies discussed during the course.
Topics Covered in Basics Course:
- Licensing of Intellectual Property: Basics and Practical Applications
- Finance and Valuation Approaches
- Contract Basics
- Strategic Alliances
- Communicating the Deal
- Negotiation and Influence Strategies
- Recent Trends In Licensing
Topics Covered in Advanced Course:
- Valuation and Deal Structuring skills
- Intellectual Property
- Due Diligence
- Negotiation and Influence Strategies
The ESF-EMBO Symposium is happy to announce that they will be hosting the second Synthetic Biology Symposium conference. The Synthetic Biology Symposium II conference will take place in Saint Feliu de Guixols, Spain from August 30th to September 4th of 2014. The European Science Foundation and European Molecular Biology organization hosted the first conference in 2011.
Since the 2011 conference, young scientists have been building upon their knowledge and research to make breakthroughs and advancements in the synthetic biology community. Organizers: Eriko and Rainer Breitling have arraned for scientists such as Timothy Lu and Christian Hertweck to attend and speak about their field of research. This conference’s main focus is to discuss the progress in synthetic biology, biochemistry and biotechnology but more specifically their relation to antibiotics.
Throughout the years there has been a significant increase in antibiotic demand and production. Scientists have been performing experiments with filamentous fungi and actinomycete bacteria to better understand the capabilities and resistance of antibiotics. The WHO’s first global report on antibiotic resistance reveals a serious, worldwide threat to public health, combating antibiotic resistance will be a major contributor to longer, healthier lives.
To read more…click ESF-EMBO
Developing Global Solutions Through Animal Biotechnology
This unique conference offers:
A focus on genetic engineering of agricultural animals including benefits, research and development, regulatory system, and challenges to advancing health, food and industrial applications of animal biotechnology.
Who should attend?
Industry and academic scientists in both biomedical and agricultural research; executives (R&D, regulatory, animal care, sales), technology transfer offices, accrediting bodies, stakeholders, and investors.
In September 2012, BIO hosted its second industry conference on genetically engineered animal technologies – participants gained knowledge and met others in the field. Join us for another gathering of the world’s leading industry, academic and government leaders in the fields of science and animal agriculture.
The Massachusetts chapter of the Association for Women In Science will be celebrating the organization’s 10th Anniversary. All are invited to Cambridge, Massachusetts for a festive luncheon including the special guest speakers Dr. Ellen Daniell and Senator Elizabeth Warren.
For years, MASS AWIS has been providing support, encouragement, and mentorship to up and coming women focused on science, technology, engineering and mathematics. These focuses are better referred to as the STEM fields. The MASS AWIS organization offers 18 mentoring programs in addition to career development guidance. The main goal of the MASS AWIS is to promote women’s equality in the workforce, more specifically the scientific field. In reinforcing this goal, the organization has asked Dr. Ellen Daniell to speak about her book Every Other Thursday: Stories and Strategies from Successful Women Scientists. In summary, her book reaches out to women who feel discouraged, overwhelmed and are struggling in the scientific academic setting. In her book, she suggests that women should congregate and create a support group, which the MASS AWIS organizations adopted.
As a woman of science entering the medical field, this celebration is extremely important for women to breakthrough the glass beaker. The MASS AWIS and other organizations similar to it are the building blocks to a strong foundation of successful and empowered female scientists.
For more information, click here
The International Genetically Engineered Machine competition (iGEM) is an undergraduate Synthetic Biology competition. Participating student teams use a kit of biological parts given to them at the beginning of the summer, along with new parts of their own, to design biological systems and operate them in living cells. Participating teams are encouraged to work on projects that address real-world challenges.
In celebration of iGEM’s 10-year anniversary this year, there will be no regional competitions, but rather, all participating teams will advance to present their projects and compete in Boston, MA.
Additionally, there will be networking sessions, social events, presentations, talks, exhibitions, workshops, and discussions forums at this year’s event.
For more information and for a detailed schedule, visit the iGEM website.
Synbiobeta brings together the elite of the synthetic biology community including investors, entrepreneurs, academics and other disciplines multiple times a year to provide networking opportunities and share the latest developments in the field.
This year’s 3rd annual conference will discuss research enabling tools, low cost DNA synthesis, the growing importance of the organism industry and the scale up of industrial biotech platforms.
To learn more about the event click here.